
Makers Laboratories Stock Falls to 52-Week Low of Rs.114.95
2025-12-02 12:44:03Makers Laboratories has reached a new 52-week low, with its share price touching Rs.114.95 today. This marks a significant decline for the pharmaceutical company amid broader market fluctuations and sector-specific pressures.
Read MoreWhy is Makers Labs. falling/rising?
2025-11-28 00:20:46Persistent Underperformance Against Benchmarks Makers Laboratories has been struggling to keep pace with the broader market indices, as evidenced by its returns relative to the Sensex. Over the past week, the stock has declined by 5.56%, while the Sensex recorded a modest gain of 0.10%. This divergence extends over longer periods, with the stock down 9.38% in the last month compared to the Sensex’s 1.11% rise. Year-to-date figures reveal a stark contrast: Makers Labs has fallen 33.86%, whereas the Sensex has appreciated by 9.70%. Even over a five-year horizon, the stock has declined by 20.38%, while the Sensex surged by 94.16%. These figures highlight a sustained period of underperformance that has weighed heavily on investor confidence. Technical Indicators Si...
Read MoreWhy is Makers Labs. falling/rising?
2025-11-13 22:12:03As of 13-Nov, Makers Laboratories Ltd is experiencing a price increase, currently at Rs 132.70, which reflects a rise of Rs 9.55 or 7.75%. The stock has shown positive momentum, gaining 13.13% over the last two days and outperforming its sector by 7.54% today. It opened with a gain of 3.05% and reached an intraday high of Rs 133.5, indicating strong buying interest. However, despite these gains, the stock's year-to-date performance remains negative at -26.71%, and it has underperformed over the longer term compared to the benchmark, with a 1-year return of -14.94% versus the Sensex's +8.74%. Additionally, there has been a decline in investor participation, with delivery volume falling by 3.81% against the 5-day average, which may indicate some caution among investors. Broader Market Context: In the short term, Makers Laboratories Ltd has outperformed the Sensex, which has only gained 1.40% over the past we...
Read More
Makers Laboratories Stock Plummets to New 52-Week Low at Rs. 117.95
2025-11-11 11:26:25Makers Laboratories has hit a new 52-week low, reflecting a notable decline in its stock performance. The company has underperformed its sector and experienced a consecutive drop over three days. Its long-term fundamentals show weakness, with decreased operating profits and low return on equity.
Read More
Makers Laboratories Stock Plummets to New 52-Week Low at Rs. 117.95
2025-11-11 11:26:12Makers Laboratories has reached a new 52-week low of Rs. 117.95, marking a significant downturn for the stock, which has underperformed its sector. The stock has declined over the past three days and is trading below multiple moving averages, reflecting a sustained downward trend amid broader market fluctuations.
Read More
Makers Laboratories Stock Plummets to New 52-Week Low at Rs. 117.95
2025-11-11 11:26:02Makers Laboratories has reached a new 52-week low, reflecting a significant decline in its stock performance. The stock has underperformed its sector and has seen a consecutive drop over three days. It is currently trading below multiple moving averages, indicating a persistent downward trend amid broader market volatility.
Read MoreIs Makers Labs. overvalued or undervalued?
2025-11-11 08:13:07As of 10 November 2025, the valuation grade for Makers Labs. has moved from very attractive to very expensive. This indicates a significant shift in the company's perceived value, suggesting that it is currently overvalued. The company's PE ratio stands at an alarming -4693.22, while its EV to EBITDA is 8.94 and EV to Sales is 0.66, which are concerning figures in the context of its financial health. In comparison to its peers, Makers Labs. is positioned unfavorably against companies like Sun Pharma. Inds., which has a PE ratio of 35.15 and an EV to EBITDA of 10.64, and Cipla, which boasts a PE ratio of 22.45 and an EV to EBITDA of 5.67. The stark contrast in these ratios highlights the overvaluation of Makers Labs. Furthermore, the company's stock has underperformed the Sensex significantly over various periods, with a year-to-date decline of 34.00% compared to the Sensex's gain of 6.91%. Overall, the evi...
Read MoreWhy is Makers Labs. falling/rising?
2025-11-10 22:02:34As of 10-Nov, Makers Laboratories Ltd is experiencing a decline in its stock price, currently at Rs 119.50, which represents a decrease of Rs 6.5 or 5.16%. The stock has been underperforming, having fallen consecutively for the last two days with a total return of -7.61%. It is also close to its 52-week low, just 0.96% away from Rs 118.35. The stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Additionally, there has been a notable decrease in investor participation, with delivery volume dropping by 14.03% compared to the 5-day average. In the broader market context, the stock's performance over the past week shows a decline of 5.57%, while the Sensex has only decreased by 0.53%, highlighting a significant underperformance relative to the benchmark. Over the past month, Makers Laboratories Ltd has fallen by 6.90%, contrasting with a 1.25% inc...
Read MoreHow has been the historical performance of Makers Labs.?
2025-11-09 22:38:12Answer: The historical performance of Makers Labs shows a fluctuating trend in net sales and profitability over the past five years. Breakdown: Makers Labs reported net sales of 120.75 Cr in March 2025, an increase from 104.39 Cr in March 2024 and 101.28 Cr in March 2023, but a decline from 126.63 Cr in March 2022. The total operating income mirrored this trend, reaching 120.75 Cr in March 2025. The company's total expenditure, excluding depreciation, was 112.36 Cr in March 2025, up from 103.34 Cr in March 2024, leading to an operating profit (PBDIT) of 8.39 Cr, a significant recovery from 1.05 Cr in the previous year. However, the operating profit margin (excluding other income) was 6.95% in March 2025, compared to 1.01% in March 2024. Profit before tax improved to 13.41 Cr in March 2025, recovering from a loss of 3.92 Cr in March 2024, while profit after tax was 10.91 Cr, a turnaround from a loss of 4.81...
Read MoreBoard Meeting Intimation for Standalone And Consolidated Financial Results For 3Rd Quarter And Nine Months Ended 31St December 2025
21-Jan-2026 | Source : BSEMakers Laboratories Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2026 inter alia to consider and approve Standalone and Consolidated Financial Results for 3rd quarter and nine months ended 31st December 2025
Re-Lodgement Of Transfer Requests Report - November 2025 And December 2025
21-Jan-2026 | Source : BSERe-lodgement of transfer requests report - November 2025 and December 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
08-Jan-2026 | Source : BSEThe Company has enclosed herewith RTA certficate under Reg 74 (5) of SEBI DP Regulations 2018 for the quarter ended 31.12.2025.
Corporate Actions
No Upcoming Board Meetings
Makers Laboratories Ltd has declared 10% dividend, ex-date: 01 Aug 19
No Splits history available
No Bonus history available
Makers Laboratories Ltd has announced 1:5 rights issue, ex-date: 30 Mar 22